In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify marijuana as being a Program III drug. This rescheduling will identify that cannabis has genuine healthcare reasons and may help open the door to exploration on other possible treatment works by using. Even so, the initial researcher https://thcdisposables.co.uk/